ScholarIQanswers from OpenAlex & ORCID
Frank L. Meyskens
ResearcherPublications, citations & collaboration network
Frank L. Meyskens is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Frank L. Meyskens have?
ScholarIQindexed works
Frank L. Meyskens has 539 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Frank L. Meyskens have?
ScholarIQcitation count
Frank L. Meyskens has 27,751 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Frank L. Meyskens?
ScholarIQh-index
Frank L. Meyskens has an h-index of 70 in OpenAlex.
What is the i10-index of Frank L. Meyskens?
ScholarIQi10-index
Frank L. Meyskens has an i10-index of 235 in OpenAlex.
What is the ORCID of Frank L. Meyskens?
ScholarIQorcid
The ORCID for Frank L. Meyskens is on the source record.
What is the OpenAlex record for Frank L. Meyskens?
ScholarIQopenalex
The OpenAlex for Frank L. Meyskens is on the source record.
What are the most-cited papers on Frank L. Meyskens?
ScholarIQmost cited works
Effects of a Combination of Beta Carotene and Vitamin A on Lung Cancer and Cardiovascular Disease
Gilbert S. Omenn, Gary E. Goodman, Mark Thornquist, John R. Balmes, Mark R. Cullen, Andrew G. Glass, James P. Keogh, Frank L. Meyskens, Barbara Valanis, James H. Williams, Scott Barnhart, Samuel P. Hammar
Risk Factors for Lung Cancer and for Intervention Effects in CARET, the Beta-Carotene and Retinol Efficacy Trial
Gilbert S. Omenn, Gary E. Goodman, Mark Thornquist, John R. Balmes, Mark R. Cullen, Andrew Glass, James P. Keogh, Frank L. Meyskens, Barbara Valanis, J. H. Williams, Scott Barnhart, Martin G. Cherniack, Carl A. Brodkin, Samuel P. Hammar
Phase IIa Clinical Trial of Curcumin for the Prevention of Colorectal Neoplasia
Robert E. Carroll, Richard V. Benya, D. Kim Turgeon, Shaiju K. Vareed, Malloree Neuman, Luz M. Rodriguez, Madhuri Kakarala, Philip M. Carpenter, Christine E. McLaren, Frank L. Meyskens, Dean E. Brenner
Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer—A Plan to Move Forward
Gary J. Kelloff, Scott M. Lippman, Andrew J. Dannenberg, Caroline C. Sigman, Homer L. Pearce, Brian J. Reid, Éva Szabó, V. Craig Jordan, Margaret R. Spitz, Gordon B. Mills, Vali A. Papadimitrakopoulou, Reuben Lotan, Bharat B. Aggarwal, Robert S. Bresalier, Jeri Kim, Banu Arun, Karen H. Lu, Melanie E. Thomas, Helen Rhodes, Molly Brewer, Michele Follen, Dong M. Shin, Howard L. Parnes, Jill M. Siegfried, Alison A. Evans, William J. Blot, Wong‐Ho Chow, Patricia L. Blount, Carlo C. Maley, Kenneth K. Wang, Stephen Lam, J. Jack Lee, Steven M. Dubinett, Paul F. Engstrom, Frank L. Meyskens, Joyce O’Shaughnessy, Ernest T. Hawk, Bernard Levin, William G. Nelson, Waun Ki Hong, for the AACR Task Force on Cancer Prevention